Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Pancreatic Cancer | Research

Prognostic assessment capability of a five-gene signature in pancreatic cancer: a machine learning based-study

Authors: Xuanfeng Zhang, Lulu Yang, Dong Zhang, Xiaochuan Wang, Xuefeng Bu, Xinhui Zhang, Long Cui

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

A prognostic assessment method with good sensitivity and specificity plays an important role in the treatment of pancreatic cancer patients. Finding a way to evaluate the prognosis of pancreatic cancer is of great significance for the treatment of pancreatic cancer.

Methods

In this study, GTEx dataset and TCGA dataset were merged together for differential gene expression analysis. Univariate Cox regression and Lasso regression were used to screen variables in the TCGA dataset. Screening the optimal prognostic assessment model is then performed by gaussian finite mixture model. Receiver operating characteristic (ROC) curves were used as an indicator to assess the predictive ability of the prognostic model, the validation process was performed on the GEO datasets.

Results

Gaussian finite mixture model was then used to build 5-gene signature (ANKRD22, ARNTL2, DSG3, KRT7, PRSS3). Receiver operating characteristic (ROC) curves suggested the 5-gene signature performed well on both the training and validation datasets.

Conclusions

This 5-gene signature performed well on both our chosen training dataset and validation dataset and provided a new way to predict the prognosis of pancreatic cancer patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33.CrossRefPubMed Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33.CrossRefPubMed
3.
go back to reference Wu M, Li X, Zhang T, Liu Z, Zhao Y. Identification of a nine-gene signature and establishment of a prognostic nomogram predicting overall survival of pancreatic cancer. Front Oncol. 2019;9:996.CrossRefPubMedPubMedCentral Wu M, Li X, Zhang T, Liu Z, Zhao Y. Identification of a nine-gene signature and establishment of a prognostic nomogram predicting overall survival of pancreatic cancer. Front Oncol. 2019;9:996.CrossRefPubMedPubMedCentral
4.
go back to reference Kamarajah SK, Burns WR, Frankel TL, Cho CS, Nathan H: Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis. Ann Surg Oncol. 2017;24:2023–2030.CrossRefPubMed Kamarajah SK, Burns WR, Frankel TL, Cho CS, Nathan H: Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis. Ann Surg Oncol. 2017;24:2023–2030.CrossRefPubMed
5.
go back to reference Xuan J, Yu Y, Qing T, Guo L, Shi L. Next-generation sequencing in the clinic: promises and challenges. Cancer Lett. 2013;340:284–95.CrossRefPubMed Xuan J, Yu Y, Qing T, Guo L, Shi L. Next-generation sequencing in the clinic: promises and challenges. Cancer Lett. 2013;340:284–95.CrossRefPubMed
6.
go back to reference Tran KA, Kondrashova O, Bradley A, Williams ED, Pearson JV, Waddell N. Deep learning in cancer diagnosis, prognosis and treatment selection. Genome Med. 2021;13:152.CrossRefPubMedPubMedCentral Tran KA, Kondrashova O, Bradley A, Williams ED, Pearson JV, Waddell N. Deep learning in cancer diagnosis, prognosis and treatment selection. Genome Med. 2021;13:152.CrossRefPubMedPubMedCentral
7.
go back to reference Sui S, An X, Xu C, Li Z, Hua Y, Huang G, Sui S, Long Q, Sui Y, Xiong Y, et al. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer. Theranostics. 2020;10:11938–49.CrossRefPubMedPubMedCentral Sui S, An X, Xu C, Li Z, Hua Y, Huang G, Sui S, Long Q, Sui Y, Xiong Y, et al. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer. Theranostics. 2020;10:11938–49.CrossRefPubMedPubMedCentral
8.
go back to reference Venner JM, Famulski KS, Badr D, Hidalgo LG, Chang J, Halloran PF. Molecular landscape of T cell-mediated rejection in human kidney transplants: prominence of CTLA4 and PD ligands. Am J Transplant. 2014;14:2565–76.CrossRefPubMed Venner JM, Famulski KS, Badr D, Hidalgo LG, Chang J, Halloran PF. Molecular landscape of T cell-mediated rejection in human kidney transplants: prominence of CTLA4 and PD ligands. Am J Transplant. 2014;14:2565–76.CrossRefPubMed
9.
go back to reference Caba O, Prados J, Ortiz R, Jimenez-Luna C, Melguizo C, Alvarez PJ, Delgado JR, Irigoyen A, Rojas I, Perez-Florido J, et al. Transcriptional profiling of peripheral blood in pancreatic adenocarcinoma patients identifies diagnostic biomarkers. Dig Dis Sci. 2014;59:2714–20.CrossRefPubMed Caba O, Prados J, Ortiz R, Jimenez-Luna C, Melguizo C, Alvarez PJ, Delgado JR, Irigoyen A, Rojas I, Perez-Florido J, et al. Transcriptional profiling of peripheral blood in pancreatic adenocarcinoma patients identifies diagnostic biomarkers. Dig Dis Sci. 2014;59:2714–20.CrossRefPubMed
10.
go back to reference Milioli HH, Tishchenko I, Riveros C, Berretta R, Moscato P. Basal-like breast cancer: molecular profiles, clinical features and survival outcomes. BMC Med Genomics. 2017;10:19.CrossRefPubMedPubMedCentral Milioli HH, Tishchenko I, Riveros C, Berretta R, Moscato P. Basal-like breast cancer: molecular profiles, clinical features and survival outcomes. BMC Med Genomics. 2017;10:19.CrossRefPubMedPubMedCentral
11.
go back to reference Yin J, Fu W, Dai L, Jiang Z, Liao H, Chen W, Pan L, Zhao J. ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1. Sci Rep. 2017;7:4430.CrossRefPubMedPubMedCentral Yin J, Fu W, Dai L, Jiang Z, Liao H, Chen W, Pan L, Zhao J. ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1. Sci Rep. 2017;7:4430.CrossRefPubMedPubMedCentral
12.
go back to reference Pan T, Liu J, Xu S, Yu Q, Wang H, Sun H, Wu J, Zhu Y, Zhou J, Zhu Y. ANKRD22, a novel tumor microenvironment-induced mitochondrial protein promotes metabolic reprogramming of colorectal cancer cells. Theranostics. 2020;10:516–36.CrossRefPubMedPubMedCentral Pan T, Liu J, Xu S, Yu Q, Wang H, Sun H, Wu J, Zhu Y, Zhou J, Zhu Y. ANKRD22, a novel tumor microenvironment-induced mitochondrial protein promotes metabolic reprogramming of colorectal cancer cells. Theranostics. 2020;10:516–36.CrossRefPubMedPubMedCentral
13.
go back to reference Luo L, Li Y, Huang C, Lin Y, Su Y, Cen H, Chen Y, Peng S, Ren T, Xie R, Zeng L. A new 7-gene survival score assay for pancreatic cancer patient prognosis prediction. Am J Cancer Res. 2021;11:495–512.PubMedPubMedCentral Luo L, Li Y, Huang C, Lin Y, Su Y, Cen H, Chen Y, Peng S, Ren T, Xie R, Zeng L. A new 7-gene survival score assay for pancreatic cancer patient prognosis prediction. Am J Cancer Res. 2021;11:495–512.PubMedPubMedCentral
14.
go back to reference Wang A, Guo H, Long Z. Integrative Analysis of Differently Expressed Genes Reveals a 17-Gene Prognosis Signature for Endometrial Carcinoma. Biomed Res Int. 2021;2021:4804694.PubMedPubMedCentral Wang A, Guo H, Long Z. Integrative Analysis of Differently Expressed Genes Reveals a 17-Gene Prognosis Signature for Endometrial Carcinoma. Biomed Res Int. 2021;2021:4804694.PubMedPubMedCentral
15.
go back to reference Li J, Chen N, Gong X. Prognostic implications of aberrantly expressed methylationdriven genes in hepatocellular carcinoma: a study based on The Cancer Genome Atlas. Mol Med Rep. 2019;20:5304–14.PubMed Li J, Chen N, Gong X. Prognostic implications of aberrantly expressed methylationdriven genes in hepatocellular carcinoma: a study based on The Cancer Genome Atlas. Mol Med Rep. 2019;20:5304–14.PubMed
16.
go back to reference Lebailly B, Langa F, Boitard C, Avner P, Rogner UC. The circadian gene Arntl2 on distal mouse chromosome 6 controls thymocyte apoptosis. Mamm Genome. 2017;28:1–12.CrossRefPubMed Lebailly B, Langa F, Boitard C, Avner P, Rogner UC. The circadian gene Arntl2 on distal mouse chromosome 6 controls thymocyte apoptosis. Mamm Genome. 2017;28:1–12.CrossRefPubMed
17.
go back to reference Brady JJ, Chuang CH, Greenside PG, Rogers ZN, Murray CW, Caswell DR, Hartmann U, Connolly AJ, Sweet-Cordero EA, Kundaje A, Winslow MM. An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-Sufficiency. Cancer Cell. 2016;29:697–710.CrossRefPubMedPubMedCentral Brady JJ, Chuang CH, Greenside PG, Rogers ZN, Murray CW, Caswell DR, Hartmann U, Connolly AJ, Sweet-Cordero EA, Kundaje A, Winslow MM. An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-Sufficiency. Cancer Cell. 2016;29:697–710.CrossRefPubMedPubMedCentral
18.
go back to reference Mazzoccoli G, Pazienza V, Panza A, Valvano MR, Benegiamo G, Vinciguerra M, Andriulli A, Piepoli A. ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer. J Cancer Res Clin Oncol. 2012;138:501–11.CrossRefPubMed Mazzoccoli G, Pazienza V, Panza A, Valvano MR, Benegiamo G, Vinciguerra M, Andriulli A, Piepoli A. ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer. J Cancer Res Clin Oncol. 2012;138:501–11.CrossRefPubMed
19.
go back to reference Ha NH, Long J, Cai Q, Shu XO, Hunter KW. The Circadian Rhythm Gene Arntl2 Is a Metastasis Susceptibility Gene for Estrogen Receptor-Negative Breast Cancer. PLoS Genet. 2016;12:e1006267.CrossRefPubMedPubMedCentral Ha NH, Long J, Cai Q, Shu XO, Hunter KW. The Circadian Rhythm Gene Arntl2 Is a Metastasis Susceptibility Gene for Estrogen Receptor-Negative Breast Cancer. PLoS Genet. 2016;12:e1006267.CrossRefPubMedPubMedCentral
20.
go back to reference Brown L, Wan H. Desmoglein 3: a help or a hindrance in cancer progression? Cancers (Basel). 2015;7:266–86.CrossRefPubMed Brown L, Wan H. Desmoglein 3: a help or a hindrance in cancer progression? Cancers (Basel). 2015;7:266–86.CrossRefPubMed
21.
go back to reference Mannan T, Jing S, Foroushania SH, Fortune F, Wan H. RNAi-mediated inhibition of the desmosomal cadherin (desmoglein 3) impairs epithelial cell proliferation. Cell Prolif. 2011;44:301–10.CrossRefPubMedPubMedCentral Mannan T, Jing S, Foroushania SH, Fortune F, Wan H. RNAi-mediated inhibition of the desmosomal cadherin (desmoglein 3) impairs epithelial cell proliferation. Cell Prolif. 2011;44:301–10.CrossRefPubMedPubMedCentral
22.
go back to reference Bunbanjerdsuk S, Vorasan N, Saethang T, Pongrujikorn T, Pangpunyakulchai D, Mongkonsiri N, Arsa L, Thokanit N, Pongsapich W, Anekpuritanang T, et al. Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy in patients with head and neck squamous cell carcinoma. Mod Pathol. 2019;32:943–56.CrossRefPubMed Bunbanjerdsuk S, Vorasan N, Saethang T, Pongrujikorn T, Pangpunyakulchai D, Mongkonsiri N, Arsa L, Thokanit N, Pongsapich W, Anekpuritanang T, et al. Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy in patients with head and neck squamous cell carcinoma. Mod Pathol. 2019;32:943–56.CrossRefPubMed
23.
go back to reference Sheng Z, Han W, Huang B, Shen G. Screening and identification of potential prognostic biomarkers in metastatic skin cutaneous melanoma by bioinformatics analysis. J Cell Mol Med. 2020;24:11613–8.CrossRefPubMedPubMedCentral Sheng Z, Han W, Huang B, Shen G. Screening and identification of potential prognostic biomarkers in metastatic skin cutaneous melanoma by bioinformatics analysis. J Cell Mol Med. 2020;24:11613–8.CrossRefPubMedPubMedCentral
24.
go back to reference Fei H, Chen S, Xu C. RNA-sequencing and microarray data mining revealing: the aberrantly expressed mRNAs were related with a poor outcome in the triple negative breast cancer patients. Ann Transl Med. 2020;8:363.CrossRefPubMedPubMedCentral Fei H, Chen S, Xu C. RNA-sequencing and microarray data mining revealing: the aberrantly expressed mRNAs were related with a poor outcome in the triple negative breast cancer patients. Ann Transl Med. 2020;8:363.CrossRefPubMedPubMedCentral
25.
go back to reference Meecham A, Marshall JF. The ITGB6 gene: its role in experimental and clinical biology. Gene X. 2020;5:100023.PubMed Meecham A, Marshall JF. The ITGB6 gene: its role in experimental and clinical biology. Gene X. 2020;5:100023.PubMed
26.
go back to reference Thomas GJ, Lewis MP, Hart IR, Marshall JF, Speight PM. AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int J Cancer. 2001;92:641–50.CrossRefPubMed Thomas GJ, Lewis MP, Hart IR, Marshall JF, Speight PM. AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int J Cancer. 2001;92:641–50.CrossRefPubMed
27.
28.
go back to reference Charli JL, Rodriguez-Rodriguez A, Hernandez-Ortega K, Cote-Velez A, Uribe RM, Jaimes-Hoy L, Joseph-Bravo P. The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target? Front Pharmacol. 2020;11:640.CrossRefPubMedPubMedCentral Charli JL, Rodriguez-Rodriguez A, Hernandez-Ortega K, Cote-Velez A, Uribe RM, Jaimes-Hoy L, Joseph-Bravo P. The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target? Front Pharmacol. 2020;11:640.CrossRefPubMedPubMedCentral
29.
go back to reference Qin W, Qi F, Li J, Li P, Zang YS. Prognostic biomarkers on a competitive endogenous RNA network reveals overall survival in triple-negative breast cancer. Front Oncol. 2021;11:681946.CrossRefPubMedPubMedCentral Qin W, Qi F, Li J, Li P, Zang YS. Prognostic biomarkers on a competitive endogenous RNA network reveals overall survival in triple-negative breast cancer. Front Oncol. 2021;11:681946.CrossRefPubMedPubMedCentral
30.
31.
go back to reference Deng GC, Sun DC, Zhou Q, Lv Y, Yan H, Han QL, Dai GH. Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancer. BMC Genomics. 2021;22:791.CrossRefPubMedPubMedCentral Deng GC, Sun DC, Zhou Q, Lv Y, Yan H, Han QL, Dai GH. Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancer. BMC Genomics. 2021;22:791.CrossRefPubMedPubMedCentral
32.
go back to reference Wei C, Liang Q, Li X, Li H, Liu Y, Huang X, Chen X, Guo Y, Li J. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer. J Cell Biochem. 2019;120:14916–27.CrossRefPubMed Wei C, Liang Q, Li X, Li H, Liu Y, Huang X, Chen X, Guo Y, Li J. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer. J Cell Biochem. 2019;120:14916–27.CrossRefPubMed
Metadata
Title
Prognostic assessment capability of a five-gene signature in pancreatic cancer: a machine learning based-study
Authors
Xuanfeng Zhang
Lulu Yang
Dong Zhang
Xiaochuan Wang
Xuefeng Bu
Xinhui Zhang
Long Cui
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02700-y

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.